CAR-T immunotherapy now approved for certain adult lymphoma patients
(PHYSorg.com Medicine & Health)

The Food and Drug Administration (FDA) has approved a breakthrough cancer therapy known as CAR-T for use in adults with advanced lymphoma. The therapy uses a patient`s own white blood cells, which are modified in a lab and re-trained to recognize specific markers on the surface of the cell and then target and kill only those cancerous cells.